Allison Luo

Chief Tech/Sci/R&D Officer at PROMETHEUS BIOSCIENCES, INC.

50 year

Health Technology

Consumer Services

Health Services

Profile

Allison Luo is currently working as Senior VP-Gastroenterology at Biora Therapeutics, Inc. and as Chief Medical Officer at Prometheus Biosciences, Inc. She previously worked as Medical Director at Abbott Laboratories, Executive Director at Bristol Myers Squibb Co., and Vice President-Clinical Development at IVERIC bio, Inc. Dr. Luo completed her undergraduate and doctorate degrees from Northwestern University.

Allison Luo active positions

Companies	Position	Start
PROMETHEUS BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	2018-07-31
BIORA THERAPEUTICS, INC.	Corporate Officer/Principal	2017-05-31

All active positions of Allison Luo

Former positions of Allison Luo

Companies	Position	End
BRISTOL-MYERS SQUIBB COMPANY	Director/Board Member	2014-09-30
IVERIC BIO, INC.	Corporate Officer/Principal	-
ABBOTT LABORATORIES	Chief Tech/Sci/R&D Officer	-

See the detail of Allison Luo's experience

Training of Allison Luo

Northwestern University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Allison Luo's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
ABBOTT LABORATORIES	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
BIORA THERAPEUTICS, INC.	Health Services

Private companies	2
IVERIC bio, Inc. IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ.	Health Technology
Prometheus Biosciences, Inc. Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .	Health Technology